|
|
|
|
| LEADER |
01734nam a22002775i 4500 |
| 001 |
000281885 |
| 005 |
20211029092256.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2008 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387775708
|
| 024 |
7 |
|
|a 10.1007/978-0-387-77570-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Drug Targets in Kinetoplastid Parasites /
|c edited by Hemanta K. Majumder.
|
| 250 |
|
|
|a 1st ed. 2008.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2008.
|
| 300 |
|
|
|a XX, 158 p. 45 illus., 1 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 625
|
| 505 |
0 |
|
|a Arsenite Resistance in Leishmania and Possible Drug Targets -- Unique Characteristics of the Kinetoplast DNA Replication Machinery Provide Potential Drug Targets in Trypanosomatids -- Drugs and Transporters in Kinetoplastid Protozoa -- Selective Lead Compounds against Kinetoplastid Tubulin -- Fishing for Anti-Leishmania Drugs: Principles and Problems -- Sterol 14-Demethylase Inhibitors for Trypanosoma cruzi Infections -- Histone Deacetylases -- Targeting Glycoproteins or Glycolipids and Their Metabolic Pathways for Antiparasite Therapy -- DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy -- Antiparasitic Chemotherapy: -- Searching the Tritryp Genomes for Drug Targets -- Purine and Pyrimidine Metabolism in Leishmania.
|
| 650 |
|
0 |
|a Parasitology.
|
| 650 |
1 |
4 |
|a Parasitology.
|
| 700 |
1 |
|
|a Majumder, Hemanta K.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|